ProPhase Labs, Inc. (PRPH)
NASDAQ: PRPH · IEX Real-Time Price · USD
-0.28 (-5.25%)
May 24, 2024, 4:30 PM EDT - Market closed

ProPhase Labs Revenue

ProPhase Labs had revenue of $28.72M in the twelve months ending March 31, 2024, down -69.59% year-over-year. Revenue in the quarter ending March 31, 2024 was $3.63M, a -81.17% decrease year-over-year. In the year 2023, ProPhase Labs had annual revenue of $44.38M, a decrease of -63.81%.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
96.35M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 202344.38M-78.26M-63.81%
Dec 31, 2022122.65M43.61M55.17%
Dec 31, 202179.04M64.53M444.59%
Dec 31, 202014.51M4.64M46.96%
Dec 31, 20199.88M-3.25M-24.76%
Dec 31, 201813.13M3.26M33.03%
Dec 31, 20179.87M5.66M134.59%
Dec 31, 20164.21M1.69M67.04%
Dec 31, 20152.52M-19.55M-88.59%
Dec 31, 201422.07M-2.96M-11.83%
Dec 31, 201325.03M2.63M11.72%
Dec 31, 201222.41M4.95M28.38%
Dec 31, 201117.45M2.95M20.35%
Dec 31, 201014.50M-5.31M-26.82%
Dec 31, 200919.82M-691.00K-3.37%
Dec 31, 200820.51M-7.73M-27.39%
Dec 31, 200728.24M1.39M5.18%
Dec 31, 200626.85M-26.81M-49.96%
Dec 31, 200553.66M9.71M22.09%
Dec 31, 200443.95M2.45M5.90%
Dec 31, 200341.50M12.08M41.05%
Dec 31, 200229.42M6.65M29.20%
Dec 31, 200122.77M7.25M46.66%
Dec 31, 200015.53M-6.79M-30.44%
Dec 31, 199922.32M-14.03M-38.60%
Dec 31, 199836.35M-33.82M-48.19%
Dec 31, 199770.17M69.12M6,585.90%
Sep 30, 19961.05M547.66K109.12%
Sep 30, 1995501.90K425.00K552.61%
Sep 30, 199476.91K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Assertio Holdings 142.05M
FONAR 102.72M
Xtant Medical Holdings 101.23M
Akoya Biosciences 93.57M
Elutia 28.99M
MSP Recovery 9.71M
Armata Pharmaceuticals 4.70M
Oramed Pharmaceuticals 674.00K
Revenue Rankings